CLYM CIK: 1768446

Climb Bio, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
148
FY22:
134
FY23:
110
FY24:
155
FY25:
106
(positive)
Change from FY21 to FY25
millions USD
FY21:
25.0
FY22:
0.60
FY23:
0.21
FY24:
62.3
FY25:
61.9
Total assets
Change from FY21 to FY25
millions USD
FY21:
173
FY22:
135
FY23:
110
FY24:
217
FY25:
168

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
6.03
FY22:
6.10
FY23:
2.83
FY24:
4.93
FY25:
6.98
(negative)
Change from FY21 to FY25
millions USD
FY21:
0.01
FY22:
0.18
FY23:
0.04
FY24:
0.38
FY25:
0.29
(positive)
Change from FY21 to FY25
millions USD
FY21:
167
FY22:
129
FY23:
108
FY24:
212
FY25:
160
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
173
FY22:
135
FY23:
110
FY24:
217
FY25:
168

All amounts in millions USD Data source:SEC EDGAR